Age-Related Bone Loss

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 98-102

  Kiel, Douglas P ^a   Rosen, Clifford J ^b   Dempster, David ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Maine Medical Center Research Institute   (United Kingdom)

^c HELEN HAYES HOSPITAL   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Aging; Epidemiology; Falls; Fracture; Hormones and receptors; Nutrition; Osteoporosis; Treatment

Indexed keywords

EID: 84889401386     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch20     Document Type: Chapter

References (75)

1. Melton LJ III, Ilstrup DM, Beckenbaugh RD, Riggs BL 1982 Hip fracture recurrence A population-based study. Clin Orthop 167:131-138.
2. Cummings SR. Nevitt MC, Browner WS, Stone K, Fox KM, En-srud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Re search Group. N Engl J Med 332:767-773.
3. Bouxsein ML 2003 Bone quality: Where do we go from here? Osteoporos Int 14(Suppl 5): 118-127.
4. Saito M, Fujii K, Soshi S, Tanaka T 2006 Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986-995.
5. Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, Delmas PD, Bouxsein ML 2006 Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39:1073-1079.
6. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK 2003 Bone loss and bone size after menopause. N Engl J Med 349:327-334.
7. Seeman E 2007 The periosteum-a surface for all seasons. Osteo poros Int 18:123-128.
8. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M 2001 Adipocyte tissue volume in bone marrow is in creased with aging and in patients with osteoporosis. Biogerontol-ogy 2:165-171.
9. Gomberg BR, Saha PK, Song HK, Hwang SN, Wehrli FW 2000 Topological analysis of trabecular bone MR images. IEEE Trans Med Imaging 19:166-174.
10. Eriksen EF, Langdahl B, Vesterby A. Rungby J, Kassem M 1999 Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women. J Bone Miner Res 14:1217-1221.
11. Weinstein RS, Hutson MS 1987 Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging. Bone 8:137-142.
12. Recker R, Lappe J, Davies KM, Heaney R 2004 Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res 19:1628-1633.
13. Lips P, Courpron P, Meunier PJ 1978 Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age. Calcif Tissue Res 26:13-17.
14. Croucher PI, Garrahan NJ, Mellish RW, Compston JE 1991 Age-related changes in resorption cavity characteristics in human tra becular bone. Osteoporos Int 1:257-261.
15. Parfitt AM 1984 Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical conse quences. Calcif Tissue Int 36(Suppl 1):S123-S128.
16. Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll E, Nevitt MC, Fox KM, Cummings SR 1995 Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 10:1778-1787.
17. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP 2000 Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 15:710-720.
18. Ross PD, Knowlton W 1998 Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13:297-302.
19. Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL 1996 Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328-333.
20. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjeari H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 11:1531-1538.
21. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Bio chemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:1526-1536.
22. Bollen AM, Kiyak HA, Eyre DR 1997 Longitudinal evaluation of a bone resorption marker in elderly subjects. Osteoporos Int 7:544-549.
23. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S 1988 Static and tetracycline-based bone histomorpho-metric data from 34 normal postmenopausal females. J Bone Miner Res 3:133-144.
24. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ 2002 Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55:693-698.
25. Heaney RP 2000 Vitamin D: How much do we need, and how much is too much? Osteoporos Int 11:553-555.
26. Rosen CJ 2005 Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353:595-603.
27. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karl-son EW, Dawson-Hughes B 2004 Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 v. Am J Clin Nutr 80:752-758.
28. Holick MF 2007 Vitamin D deficiency. N Engl J Med 357:266-28!.
29. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB 2004 Effect of vitamin D on falls: A meta-analysis. JAMA 291:1999-2006.
30. Bischoff-Ferrari HA, Willett WC, Wong JB. Giovannucci E, Dietrich T, Dawson-Hughes B 2005 Fracture prevention with vi tamin D supplementation: A meta-analysis of randomized con trolled trials. JAMA 293:2257-2264.
31. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676.
32. Recker RR, Hinders S, Davies KM, Heaney RP, Stegman MR, Lappe JM, Kimmel DB 1996 Correcting calcium nutritional defi ciency prevents spine fractures in elderly women. J Bone Miner Res 11:1961-1966.
33. NIH 2000 Osteoporosis Prevention, Diagnosis and Therapy. NIH Consensus Development Conference, vol. 17. NIH, Washington, DC.
34. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP 2007 Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 85:1586-1591.
35. Aloia JF, Li-Ng M 2007 Correspondence. Epidemiol Infect 135:1095-1098.
36. Dawson-Hughes B, Harris SS 2002 Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women. Am J Clin Nutr 75:773-779.
37. Hannan MT, Tucker KL, Dawson-Hughes B, Cupples LA, Felson DT, Kiel DP 2000 Effect of dietary protein on bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 15:2504-2512.
38. Tucker KL, Chen H, Hannan MT, Cupples LA, Wilson PW, Felson D, Kiel DP 2002 Bone mineral density and dietary patterns in older adults: The Framingham Osteoporosis Study. Am J Clin Nutr 76:245-252.
39. Schurch MA, Rissoli R, Slosman D, Vadas L, Vergnaud P, Bon-jour JP 1998 Protein supplements increase serum insulin-like growth factor-! levels and attenuate proximal femur bone loss in patients with recent hip fracture a randomized, double-blind, pla cebo-controlled trial. Ann Intern Med 128:801-809.
40. McKeown NM, Jacques PF, Gundberg CM, Peterson JW, Tucker KL, Kiel DP. Wilson PW, Booth SL 2002 Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J Nutr 132:1329-1334.
41. Promislow JH. Goodman-Gruen D, Slymen DJ, Barrett-Connor E 2002 Retinol intake and bone mineral density in the elderly: The Rancho Bernardo Study. J Bone Miner Res 17:1349-1358.
42. Michaelsson K, Lithell H, Vessby B, Melhus H 2003 Serum retinol levels and the risk of fracture. N Engl J Med 348:287-294.
43. Slemenda C, Flui SL, Longcope C, Johnston CC 1987 Sex steroids and bone mass: A study of changes about the time of menopause. J Clin Invest 80:1261-1269.
44. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PW, Felson DT 2000 Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133:951-963.
45. Greendale GA, Edelstein S, Barrett-Connor E 1997 Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study. J Bone Miner Res 12:1833-1843.
46. Akhter MP, Lappe JM, Davies KM, Recker RR 2007 Transmeno-pausal changes in the trabecular bone structure. Bone 41:111-116.
47. Amin S, Zhang Y, Felson DT, Sawin CT, Hannan MT, Wilson PW. Kiel DP 2006 Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119:426-433.
48. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560.
49. Khosla S, Atkinson EJ, Dunstan CR, O'Fallon WM 2002 Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 87:1550-1554.
50. Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, Kantoff PW 2002 Changes in body compo sition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87:599-603.
51. Rosen CJ, Donahue LR, Hunter SJ 1994 Insulin-like growth fac tors and bone: The osteoporosis connection. Proc Soc Exp Biol Med 206:83-102.
52. Bauer DC, Rosen CJ, Cauley J, Cummings SR 1997 Low serum IGF-I but not IGFBP-3 predicts hip and spine fractures. Bone 20(Suppl):561.
53. Barrett-Connor E, Kritz-Silverstein D, Edelstein SL 1993 A pro spective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women. Am J Epidemiol 137:201-206.
54. Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E 2007 The sex-specific association of serum osteoprotegerin and receptor ac tivator of nuclear factor kappaB legend with bone mineral density in older adults: The Rancho Bernardo study. Eur J Endocrinol 156:555-562.
55. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S 2002 Changes in bone structure and mass with ad vancing age in the male C57BL/6J mouse. J Bone Miner Res 17:1044-1050.
56. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer WG 2005 Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res 20:1085-1092.
57. Deng HW, Mahaney MC. Williams JT, Li J, Conway T, Davies KM, Li JL, Deng H, Recker RR 2002 Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol 22:12-25.
58. Nevitt MC, Johnell O, Black DM, Ensrud K. Genant HK, Cummings SR 1994 Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int 4:325-331.
59. Mathias A, Nayak USL, Isaacs B 1986 Balance in elderly patients: The "get-up and go" test. Arch Phys Med Rehabil 67:387-389.
60. Tinetti ME 1986 Performance-oriented assessment of mobility problems in elderly patients, J Am Geriatr Soc 34:119-126.
61. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS. Ostir GV, Studenski S, Berkman LF. Wallace RB 2000 Lower extremity function and subsequent disability: Consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 55:M221-M231.
62. Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ 2002 Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study. J Am Geriatr Soc 50:1644-1650.
63. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH 2003 Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 4:CD000340.
64. Greenspan SL, Myers E, Kiel DP, Parker RA, Hayes WC, Resnick NM 1998 Fall direction, bone mineral density, and function: Risk factors for hip fracture in frail nursing home elderlv. Am J Med 104:539-545.
65. Parker MJ, Gillespie WJ, Gillespie LD 2006 Effectiveness of hip protectors for preventing hip fractures in elderly people: System atic review. BMJ 332:571-574.
66. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Ran domised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541.
67. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY 2001 Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333-340.
68. Chesnut IC, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD 2004 Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241-1249.
69. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F. Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR 2007 Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809-1822.
70. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S 2007 Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. N Engl J Med 357:1799-1809.
71. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, La Croix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB 2003 Effects of estrogen plus progestin on risk of fracture and bone mineral den sity: The Women's Health Initiative randomized trial. JAMA 290:1729-1738.
72. Rossouw JE. Anderson GL, Prentice RL, LaCroix AZ, Kooper-berg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Prin cipal results From the Women's Health Initiative randomized con trolled trial. JAMA 288:321-333.
73. Chesnut CH III, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D 2000 A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteopo rotic fractures study. PROOF Study Group. Am J Med 109:267-276.
74. Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM, Hoszowski K, Varela AR, Fiore C, Brixen K, Reginster JY, Boonen S 2006 Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21:1113-1120.
75. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.